Submitted by Anonymous (not verified) on 6 February 2026 - 14:52
Human medicines European public assessment report (EPAR): Tuznue, trastuzumab, Date of authorisation: 19/09/2024, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Tuznue, trastuzumab, Date of authorisation: 19/09/2024, Revision: 3, Status: Authorised